GoodRx Holdings

GDRX · NASDAQ

$3.52+$0.15 (+4.45%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $3.37

Latest news

NewsOct 5, 7:12 AM ET
Full Transcript: GoodRx Holdings Q2 2026 Earnings Call
Press releaseSep 3, 9:00 AM ETBusiness Wire
From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
NewsAug 5, 4:08 PM ET
GoodRx Holdings Q2 Adj. EPS $0.08, Inline, Sales $200.411M Beat $193.162M Estimate
Press releaseAug 5, 4:05 PM ETBusiness Wire
GoodRx Reports Second Quarter 2026 Results
Press releaseJul 9, 4:05 PM ETBusiness Wire
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
Press releaseMay 27, 9:00 AM ETBusiness Wire
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
NewsMay 13, 7:52 AM ETAvi Kapoor
Why Jim Cramer Says 'Pull The Trigger' On Chevron
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 4:47 PM ET
GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate
Press releaseMay 6, 4:05 PM ETBusiness Wire
GoodRx Reports First Quarter 2026 Results
Press releaseMay 1, 8:10 AM ETBusiness Wire
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
Press releaseApr 17, 4:05 PM ETBusiness Wire
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
NewsApr 15, 1:25 PM ETVandana Singh
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market
Press releaseApr 15, 9:00 AM ETBusiness Wire
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
NewsApr 9, 8:51 AM ETNabaparna Bhattacharya
What's Going On With GoodRx Stock Thursday?
Press releaseApr 9, 7:30 AM ETBusiness Wire
GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
Press releaseMar 11, 9:00 AM ETBusiness Wire
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
Press releaseMar 6, 9:00 AM ETBusiness Wire
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®
NewsFeb 27, 9:01 AM ET
A Glimpse Into The Expert Outlook On GoodRx Holdings Through 4 Analysts
NewsFeb 26, 12:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsFeb 26, 7:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseFeb 24, 9:00 AM ETBusiness Wire
GoodRx Expands Into Employer Market With Launch of "GoodRx Employer Direct"
Press releaseFeb 5, 7:44 PM ETBusiness Wire
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
Press releaseFeb 2, 9:00 AM ETBusiness Wire
GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
Press releaseJan 28, 4:05 PM ETBusiness Wire
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
NewsJan 22, 5:01 PM ET
Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews
Press releaseJan 13, 8:00 AM ETBusiness Wire
Surescripts and GoodRx Partner to Advance Patient Price Transparency
Press releaseJan 8, 9:00 AM ETBusiness Wire
GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies
NewsJan 5, 12:23 PM ETVandana Singh
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost
Press releaseJan 5, 8:05 AM ETBusiness Wire
GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill
Press releaseDec 16, 4:05 PM ETBusiness Wire
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
NewsNov 17, 1:01 PM ETVandana Singh
Novo Nordisk Leans Into Affordability Amid Rising Competition
Press releaseNov 17, 8:35 AM ETBusiness Wire
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
NewsNov 6, 2:40 PM ET
CBS Reporter Jennifer Jacobs Posts On X "News: Other drug websites such as GoodRx won't be partnering with TrumpRx, sources told me. One official cleared up misunderstandings about what TrumpRx will be, saying the federal govt website will send consumers to the pharmaceutical companies' websites, where they can purchase buy prescription drugs directly. The companies will decide how to fulfill those orders – via their own in-house logistics or by partnering with a 3rd-party platform"
Press releaseNov 4, 4:05 PM ETBusiness Wire
GoodRx Reports Third Quarter 2025 Results
NewsOct 21, 1:38 AM ETVishaal Sanjay
Mark Cuban Isn't Convinced TrumpRx Is Going To 'Change The Game' But He's Giving Them 'Credit For Trying'
NewsAug 18, 1:15 PM ETAvi Kapoor
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August
Press releaseFeb 18, 9:00 AM ETBusiness Wire
GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
Press releaseNov 13, 7:00 AM ETBusiness Wire
Harrow Launches Access and Affordability Program with Price Reductions for Branded Products

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Full Transcript: GoodRx Holdings Q2 2026 Earnings Call

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

GoodRx Holdings Q2 Adj. EPS $0.08, Inline, Sales $200.411M Beat $193.162M Estimate

GoodRx Reports Second Quarter 2026 Results

GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

Why Jim Cramer Says 'Pull The Trigger' On Chevron

Earnings Scheduled For May 6, 2026

GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate

GoodRx Reports First Quarter 2026 Results

GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients

GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call

GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market

GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price

What's Going On With GoodRx Stock Thursday?

GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®

A Glimpse Into The Expert Outlook On GoodRx Holdings Through 4 Analysts

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GoodRx Expands Into Employer Market With Launch of "GoodRx Employer Direct"

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews

Surescripts and GoodRx Partner to Advance Patient Price Transparency

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost

GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill

GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Novo Nordisk Leans Into Affordability Amid Rising Competition

GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

GoodRx Reports Third Quarter 2025 Results

Mark Cuban Isn't Convinced TrumpRx Is Going To 'Change The Game' But He's Giving Them 'Credit For Trying'

Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August

GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

Harrow Launches Access and Affordability Program with Price Reductions for Branded Products